Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04696731 |
Title | Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (TRAVERSE) |
Acronym | TRAVERSE |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Allogene Therapeutics |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | TERMINATED | Duarte | California | 91010 | United States | Details |
UCLA Medical Center | RECRUITING | Los Angeles | California | 90095 | United States | Details |
UCSF Medical Center | RECRUITING | San Francisco | California | 94143 | United States | Details |
Yale School of Medicine | RECRUITING | New Haven | Connecticut | 06520 | United States | Details |
Georgetown University Hospital | RECRUITING | Washington | District of Columbia | 20007 | United States | Details |
Moffitt Cancer Center | RECRUITING | Tampa | Florida | 33612 | United States | Details |
Karmanos Cancer Institute | RECRUITING | Detroit | Michigan | 48201 | United States | Details |
Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10065 | United States | Details |
Providence Portland Medical Center | ACTIVE_NOT_RECRUITING | Portland | Oregon | 97213 | United States | Details |
MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |